Clinical Trial Update: BE Study of Metformin GSK 500mg [Phase 2]

View source ↗

Summary

A Phase 2 bioequivalence study of metformin 500 mg by GlaxoSmithKline has completed, with results posted in 2017, in the context of diabetic foot.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetic Foot | Phase 2 | Status: COMPLETED | Results posted: 2017-06-02